MSN Labs enters into licence agreement with DRDE for COVID-19 drug 2-DG
Drug firm MSN Laboratories on Friday said it has entered into a licence agreement with the Defence Research & Development Establishment (DRDE) for the manufacturing, distribution and marketing of 2-Deoxy-D-Glucose (2-DG), used for the treatment of COVID-19. Developed by DRDO, 2-DG has been granted permission by the Drug Controller General of India (DCGI) for emergency […]
MSN Labs enters into licence agreement with DRDE for COVID-19 drug 2-DG Read More »